1. MicroRNA-1252-5p Associated with Extracellular Vesicles Enhances Bortezomib Sensitivity in Multiple Myeloma Cells by Targeting Heparanase
   Dorival Mendes Rodrigues-Junior et al, 2021, OncoTargets and Therapy CrossRef
2. Prediction of competing endogenous RNA coexpression network as prognostic markers in AML
   Jun-Dan Wang et al, 2019, Aging CrossRef
3. Knockdown of lncRNA BDNF-AS inhibited the progression of multiple myeloma by targeting the miR-125a/b-5p-BCL2 axis
   Min Chu et al, 2022, Immunity & Ageing CrossRef
4. The Value of Serum MicroRNA Expression Signature in Predicting Refractoriness to Bortezomib-Based Therapy in Multiple Myeloma Patients
   Paweł Robak et al, 2020, Cancers CrossRef
5. Exploring the time-dependent regulatory potential of microRNAs in breast cancer cells treated with proteasome inhibitors
   Katerina Katsaraki et al, 2023, Clinical and Translational Oncology CrossRef